Medartis Holding AG (SWX:MED)
Switzerland · Delayed Price · Currency is CHF 90.10
-0.30 (-0.33%)
Aug 21, 2026, 5:31 PM CET
Medartis Holding AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 307.05 | 269.26 | 224.83 | 212.01 | 182.82 | 159.88 | |
Revenue Growth | 29.92% | 19.76% | 6.05% | 15.96% | 14.35% | 25.25% |
Cost of Revenue | 69.16 | 64.93 | 46.15 | 44.43 | 33.34 | 25.77 |
Gross Profit | 237.89 | 204.33 | 178.68 | 167.57 | 149.49 | 134.11 |
Selling, General & Admin | 196.9 | 172.72 | 140.51 | 131.99 | 126.03 | 103.05 |
Research & Development | 34.14 | 31.44 | 25.24 | 25.91 | 25.33 | 20.05 |
Other Operating Expenses | -2.04 | -2.68 | 0.13 | - | - | - |
Operating Expenses | 229 | 201.49 | 165.87 | 157.9 | 151.36 | 123.09 |
Operating Income | 8.89 | 2.85 | 12.81 | 9.68 | -1.87 | 11.01 |
Interest Expense | -3.44 | -7.48 | -5.39 | -0.83 | -0.73 | -0.75 |
Interest & Investment Income | 3.97 | 1.31 | 1.33 | 0.34 | 0.25 | 0.14 |
Earnings From Equity Investments | - | 0.98 | 0.64 | -0.57 | -0.05 | 0.04 |
Currency Exchange Gain (Loss) | -5.2 | -5.2 | 0.11 | -4.55 | -3.19 | -1.43 |
Other Non Operating Income (Expenses) | -1.86 | -1.86 | -1.42 | -0.91 | -0.66 | -0.72 |
EBT Excluding Unusual Items | 2.37 | -9.4 | 8.08 | 3.15 | -6.25 | 8.29 |
Asset Writedown | - | - | -17.86 | - | - | - |
Legal Settlements | - | - | 0.6 | - | - | - |
Other Unusual Items | 20.39 | 22.19 | 6.88 | -1.36 | -0.9 | - |
Pretax Income | 22.66 | 12.79 | 2.5 | 1.79 | -7.15 | 8.29 |
Income Tax Expense | 7.05 | 3.45 | -1.03 | 1.17 | -1.36 | 1.45 |
Earnings From Continuing Operations | 15.61 | 9.34 | 3.53 | 0.62 | -5.78 | 6.84 |
Minority Interest in Earnings | -0.69 | -0.99 | - | - | - | - |
Net Income | 14.92 | 8.35 | 3.53 | 0.62 | -5.78 | 6.84 |
Net Income to Common | 14.92 | 8.35 | 3.53 | 0.62 | -5.78 | 6.84 |
Net Income Growth | - | 136.65% | 469.95% | - | - | - |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Change | 0.56% | 0.32% | 1.10% | 3.69% | 0.29% | 0.27% |
EPS (Basic) | 1.20 | 0.67 | 0.29 | 0.05 | -0.49 | 0.58 |
EPS (Diluted) | 1.20 | 0.67 | 0.28 | 0.05 | -0.49 | 0.58 |
EPS Growth | - | 139.28% | 460.01% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 5.72 | 16.15 | 24.9 | 5.05 | -19.36 | 12.97 |
Free Cash Flow Per Share | 0.46 | 1.30 | 2.01 | 0.41 | -1.64 | 1.10 |
Gross Margin | 77.48% | 75.89% | 79.47% | 79.04% | 81.77% | 83.88% |
Operating Margin | 2.90% | 1.06% | 5.70% | 4.56% | -1.02% | 6.89% |
Profit Margin | 4.86% | 3.10% | 1.57% | 0.29% | -3.16% | 4.28% |
Free Cash Flow Margin | 1.86% | 6.00% | 11.07% | 2.38% | -10.59% | 8.11% |
EBITDA | 29.08 | 19.57 | 26.89 | 22.93 | 8.99 | 20 |
EBITDA Margin | 9.47% | 7.27% | 11.96% | 10.82% | 4.92% | 12.51% |
D&A For EBITDA | 20.19 | 16.73 | 14.08 | 13.25 | 10.86 | 8.98 |
EBIT | 8.89 | 2.85 | 12.81 | 9.68 | -1.87 | 11.01 |
EBIT Margin | 2.90% | 1.06% | 5.70% | 4.56% | -1.02% | 6.89% |
Effective Tax Rate | 31.10% | 27.00% | - | 65.48% | - | 17.51% |